CoreCap Advisors’s CVS Health CVS Stock Holding History

CoreCap Advisors’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$290K	Sell	3,386 -95	-3%	-$9.3K	0.01%	710
2026 Q2	$360K	Buy	3,481 +139	+4%	+$12.4K	0.01%	655
2026 Q1	$240K	Sell	3,342 -41	-1%	-$3.16K	0.01%	743
2025 Q4	$268K	Sell	3,383 -357	-10%	-$28.1K	0.01%	691
2025 Q3	$282K	Sell	3,740 -268	-7%	-$18.4K	0.01%	693
2025 Q2	$276K	Sell	4,008 -365	-8%	-$23.9K	0.01%	655
2025 Q1	$296K	Buy	4,373 +45	+1%	+$2.69K	0.01%	592
2024 Q4	$194K	Buy	4,328 +679	+19%	+$38.1K	0.01%	716
2024 Q3	$229K	Buy	+3,649	New	+$213K	0.01%	636
2024 Q2	–	Sell	-3,607	Closed	-$288K	–	1824
2024 Q1	$288K	Buy	3,607 +550	+18%	+$42K	0.02%	538
2023 Q4	$241K	Buy	3,057 +186	+6%	+$13.2K	0.02%	515
2023 Q3	$200K	Buy	+2,871	New	+$203K	0.01%	507
2022 Q4	$515K	Buy	5,523 +929	+20%	+$89.6K	0.04%	347
2022 Q3	$438K	Buy	4,594 +1,705	+59%	+$169K	0.04%	338
2022 Q2	$268K	Sell	2,889 -805	-22%	-$78.6K	0.02%	447
2022 Q1	$374K	Sell	3,694 -323	-8%	-$33.9K	0.03%	368
2021 Q4	$414K	Buy	+4,017	New	+$371K	0.03%	390

Other funds holding CVS

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.31B AUM 20.77% 1-Year Est. Return

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

CoreCap Advisors's CVS Position: Q3 2026 in Review

CoreCap Advisors reduced its CVS Health (CVS) stake by 2.7% in Q3 2026, selling an estimated $9.3K and leaving 3,386 shares worth $290K. The position accounts for 0.01% of the portfolio, ranked #710.

CoreCap Advisors first reported a position in CVS in Q4 2021 and has held it in 17 quarters since. The position peaked at $515K in Q4 2022. 492 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

CoreCap Advisors held 3,386 shares of CVS Health worth $290K as of Q3 2026.
CoreCap Advisors sold 95 CVS Health shares in Q3 2026, an estimated $9.3K.
CVS Health made up 0.01% of CoreCap Advisors's portfolio in Q3 2026, its #710 holding.
CoreCap Advisors first reported a position in CVS Health in Q4 2021 and has held it in 17 quarters since.
CoreCap Advisors's CVS Health position peaked at $515K in Q4 2022.
492 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.